Novocure Ltd. (NVCR)
Current
- (-)
After Hours
Rating Performance
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
+0.0% vs
Rating Accuracy
0% (0 of 0*)
Rating Return
-44.16% vs
Rating Accuracy
0% (0 of 1*)
Rating Return
-64.55% vs
Rating Accuracy
25.0% (1 of 4*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+0.0%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
+19.53%
FV Accuracy
2 Hits (4.65% Hit Rate)
FV Avg. Distance
-17.17%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
Asaf Danziger
Employees
782
Industry
Specialized Medical Devices
Sector
Healthcare
Headquarters
St. Helier
Exchange
NASDAQ
Website
http://www.novocure.comSummary Stats
Market Cap
7.67B
Revenue
545M
Net Income
-68.2M
EPS
-$0.66
Price-to-Earnings
-111.72
Price-to-Book
17.36
Debt-to-Equity
1.63
News
Analyst Ratings
Price targets projected by 8 analysts
High
$200.00
Average
$126.00
Low
$86.00
Ratings calculated by 9 analysts
Buy
3
Hold
5
Sell
1
Last Dividend
Amount
-
Dividend Date
-
Frequency
-
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q2 2022
Missed by -$0.08
-$0.23 -53.3%
-0.15
-0.14
Down 64%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--